Agility has received a Wholesaler Distribution Authorisation (for Medicines for Human Use) from the UK Medicines Healthcare & Regulatory Agency (MHRA). The certification, referred to as WDA(H), authorises warehousing and cross-dock of a wide range of pharmaceuticals, including finished products and active pharmaceutical ingredients (API) under ambient and cold chain conditions.
The certification covers the Agility-managed pharma storage facility at London’s Heathrow Airport and a second pharma competence centre in Bristol. The WDA(H) allows Agility to provide a number of additional services, including pick-and-pack operations for the distribution of stored products to hospitals, pharmacies and other distributors, the re-packing into active and passive shipping configurations, and the distribution of clinical trial materials.
With this new certification, the 3PL is able to expand its Life Science service offerings in the UK and operate on behalf of customers, particularly virtual wholesalers, brokers and importers. The certification also provides Agility with flexibility for post-Brexit import and export regulations.